Chemotherapy is the mainstay of treatment in mid-advanced tumors. Considering their
toxicity on hematopoietic cells, chemotherapeutics are often considered as …

Background Immunotherapy has been shown to be effective as a first-line treatment option
for non-small cell lung cancer (NSCLC) patients. Unfortunately, it has failed to acquire an …

Classical tumor therapy consists of surgery, radio (RT)-and/or chemotherapy. Additive
immunotherapy has gained in impact and antitumor in situ immunization strategies are …

Wogonin exerts effective antitumor activities through direct cytotoxicity against cancer cells
and indirect immune modulation. However, the molecular mechanisms of these activities …

Peptides have attracted much interest as a platform for the induction of therapeutic T cell
responses, ever since the discovery of MHC-presented protein fragments (peptides) as the …

Background Neoadjuvant chemotherapy (NAC) is being used as first line treatment in
women with large and locally advanced breast cancers (LLABCs). However, the response to …

Les chimiothérapies actuelles manquent encore souvent d'efficacité et présentent de
nombreux effets secondaires délétères. De ce fait, de nouvelles stratégies émergent, avec …